[go: up one dir, main page]

TN2018000135A1 - Extraction et exploitation de Kératine béta, la Kératine béta et ses dérivées. - Google Patents

Extraction et exploitation de Kératine béta, la Kératine béta et ses dérivées.

Info

Publication number
TN2018000135A1
TN2018000135A1 TNP/2018/000135A TN2018000135A TN2018000135A1 TN 2018000135 A1 TN2018000135 A1 TN 2018000135A1 TN 2018000135 A TN2018000135 A TN 2018000135A TN 2018000135 A1 TN2018000135 A1 TN 2018000135A1
Authority
TN
Tunisia
Prior art keywords
keratin
extraction
beta keratin
beta
protein
Prior art date
Application number
TNP/2018/000135A
Other languages
English (en)
Inventor
Ghidhaoui Abir
Original Assignee
Ghidhaoui Abir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ghidhaoui Abir filed Critical Ghidhaoui Abir
Priority to TNP/2018/000135A priority Critical patent/TN2018000135A1/fr
Priority to PCT/TN2019/000004 priority patent/WO2019209188A1/fr
Publication of TN2018000135A1 publication Critical patent/TN2018000135A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/002—Preparations for repairing the hair, e.g. hair cure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30—Characterized by the absence of a particular group of ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)

Abstract

L'extraction innovante et le nouveau solvant inventé ont permis l'extraction de la protéine de la kératine béta en toute sa conformité et sa stabilité. Cette protéine est favorisée par rapport la kératine alpha, pour l'utilisation humaine, car elle ne nécessite pas l'addition des produits chimique et des fixateurs pour qu'elle puisse donner un effet. La kératine béta est destinée pour l'industrie pharmaceutique, parapharmaceutique et cosmétique. La technique et la protéine sont utilisées par le laboratoire d'industrie pharmaceutique et parapharmaceutique, en exclusivité, Aujourd'hui.
TNP/2018/000135A 2018-04-24 2018-04-24 Extraction et exploitation de Kératine béta, la Kératine béta et ses dérivées. TN2018000135A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TNP/2018/000135A TN2018000135A1 (fr) 2018-04-24 2018-04-24 Extraction et exploitation de Kératine béta, la Kératine béta et ses dérivées.
PCT/TN2019/000004 WO2019209188A1 (fr) 2018-04-24 2019-02-19 Extraction et exploitation de kératine béta, la kératine béta et ces dérivées

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TNP/2018/000135A TN2018000135A1 (fr) 2018-04-24 2018-04-24 Extraction et exploitation de Kératine béta, la Kératine béta et ses dérivées.

Publications (1)

Publication Number Publication Date
TN2018000135A1 true TN2018000135A1 (fr) 2019-10-04

Family

ID=66530404

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP/2018/000135A TN2018000135A1 (fr) 2018-04-24 2018-04-24 Extraction et exploitation de Kératine béta, la Kératine béta et ses dérivées.

Country Status (2)

Country Link
TN (1) TN2018000135A1 (fr)
WO (1) WO2019209188A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250353887A1 (en) * 2022-05-27 2025-11-20 Stimlabs Llc Keratin Protein Extracts, Compositions, Methods and Uses Thereof
FR3161359A1 (fr) 2024-04-19 2025-10-24 Hkvor Procede d’extraction de keratine humaine a partir de cheveux

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2487197A2 (fr) * 1979-05-11 1982-01-29 Thomas Andre Procede ameliore d'extraction et de traitement de glycoproteines et/ou de mucopolysaccharides et de substances qui les accompagnent
MXPA05005597A (es) * 2002-11-28 2005-07-26 Keratec Ltd Formulaciones para el cuidado personal con queratina.
CA2845266C (fr) * 2011-08-17 2020-07-21 Keranetics Llc Procedes d'extraction de proteines de la keratine

Also Published As

Publication number Publication date
WO2019209188A9 (fr) 2019-12-05
WO2019209188A1 (fr) 2019-10-31

Similar Documents

Publication Publication Date Title
EA202091711A1 (ru) ГЕТЕРОЦИКЛИЛАМИНОЗАМЕЩЕННЫЕ ТРИАЗОЛЫ В КАЧЕСТВЕ МОДУЛЯТОРОВ Rho-АССОЦИИРОВАННОЙ ПРОТЕИНКИНАЗЫ
BR112018013827A2 (pt) moduladores de 5?-nucleotidase, ecto e uso dos mesmos
MX2020009856A (es) Rimegepant para trastornos relacionados con el peptido relacionado con el gen para calcitonina (cgrp).
MX2021007570A (es) Composiciones de agente de arni de la proteina precursora del amiloide (app) y metodos de uso de las mismas.
EA201990221A1 (ru) 1,3-дигидроксифенильные производные, применимые в качестве иммуномодуляторов
CL2018003178A1 (es) Composición farmacéutica
TN2018000135A1 (fr) Extraction et exploitation de Kératine béta, la Kératine béta et ses dérivées.
CL2017001983A1 (es) Composiciones farmacéuticas para terapia combinada.
EA201890198A1 (ru) Новые белки, специфичные в отношении lag-3
CL2019003404A1 (es) Péptido asociados a tumor (tumap) aislado; ácido nucleico; vector de expresión; célula huésped recombinante que comprendes el péptido; método para producir el péptido; uso para preparar un medicamento útil rara tratar el cáncer; kit farmacéutico.(divisional solicitud 201702407)
EA201991951A1 (ru) Низковязкие высококонцентрированные составы на основе эволокумаба и способы их получения
EP4553065A3 (fr) Nouveaux composés pour le traitement d'une maladie mitochondriale
MX2020010178A (es) Composiciones para el peinado del cabello que comprenden poligalactomanos y un metodo para el uso de las mismas.
WO2020257278A3 (fr) Protéines bromo/acétyle cibles à petites molécules et leurs utilisations
MA46548A (fr) Fsh pour le traitement de l'infertilité
EA202193245A1 (ru) Жидкая композиция ботулинического токсина для лечения межбровных морщин и боковых периорбитальных морщин от умеренных до сильно выраженных
EP3957314A4 (fr) Utilisation d'extrait de peau de lapin enflammée par le virus de la vaccine dans le traitement d'une lésion du système hématopoïétique
EP3881849A4 (fr) Composition comprenant un aptamère en tant que principe actif pour le traitement et la prévention d'une maladie dégénérative du cerveau
CO2018011420A2 (es) Formulaciones líquidas de fosfaplatino
WO2020214100A3 (fr) Composition
PH12021552324A1 (en) Carbamoyl cyclohexane derivatives for treating autism spectrum disorder
EA202190766A1 (ru) Иммуномодуляторы, их композиции и способы применения
MX2023004807A (es) Composiciones y metodos para el tratamiento de la celiaquia.
EA202190014A1 (ru) Композиция, содержащая глицирризин, и ее косметическое средство и фармацевтические применения
BR112021006643A8 (pt) Composições e métodos para aumentar capacidade de distribuição sistêmica, tolerância e eficácia de peptídeos macrocíclicos catiônicos